Creative Planning Increases Stake in The Allstate Co. (NYSE:ALL)

Creative Planning lifted its stake in The Allstate Co. (NYSE:ALL) by 5.2% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 66,823 shares of the insurance provider’s stock after buying an additional 3,280 shares during the quarter. Creative Planning’s holdings in Allstate were worth $12,673,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of ALL. Northwest Investment Counselors LLC bought a new position in shares of Allstate during the 1st quarter valued at about $26,000. Versant Capital Management Inc lifted its position in Allstate by 70.9% during the second quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock valued at $30,000 after purchasing an additional 78 shares during the last quarter. Family Firm Inc. purchased a new stake in shares of Allstate during the 2nd quarter valued at about $38,000. MCF Advisors LLC increased its stake in Allstate by 33.9% during the second quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock worth $53,000 after acquiring an additional 84 shares during the last quarter. Finally, Sunbelt Securities Inc. lifted its stake in shares of Allstate by 38.5% in the 1st quarter. Sunbelt Securities Inc. now owns 363 shares of the insurance provider’s stock valued at $63,000 after purchasing an additional 101 shares during the last quarter. Institutional investors own 76.47% of the company’s stock.

Allstate Price Performance

ALL opened at $192.64 on Tuesday. The firm has a market capitalization of $50.84 billion, a PE ratio of 42.53, a price-to-earnings-growth ratio of 1.74 and a beta of 0.48. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.36 and a quick ratio of 0.36. The business’s 50-day moving average is $187.08 and its two-hundred day moving average is $173.96. The Allstate Co. has a 1 year low of $121.70 and a 1 year high of $198.79.

Allstate (NYSE:ALL) last issued its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $1.61 EPS for the quarter, beating the consensus estimate of $0.33 by $1.28. Allstate had a return on equity of 24.05% and a net margin of 5.03%. The firm had revenue of $15.71 billion during the quarter, compared to analyst estimates of $14.04 billion. During the same quarter in the prior year, the business posted ($4.42) EPS. The business’s revenue for the quarter was up 12.4% compared to the same quarter last year. Research analysts anticipate that The Allstate Co. will post 15.19 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, EVP Elizabeth Brady sold 49,481 shares of the stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $179.09, for a total value of $8,861,552.29. Following the completion of the transaction, the executive vice president now directly owns 19,163 shares of the company’s stock, valued at $3,431,901.67. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other Allstate news, EVP Elizabeth Brady sold 49,481 shares of Allstate stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the completion of the sale, the executive vice president now owns 19,163 shares of the company’s stock, valued at approximately $3,431,901.67. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Thomas J. Wilson sold 90,000 shares of the stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $179.34, for a total value of $16,140,600.00. Following the completion of the transaction, the chief executive officer now directly owns 88,552 shares in the company, valued at $15,880,915.68. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 192,530 shares of company stock valued at $34,967,665. 1.80% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on ALL. TD Cowen raised their price target on Allstate from $193.00 to $224.00 and gave the stock a “buy” rating in a research report on Tuesday, September 3rd. StockNews.com cut Allstate from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, August 21st. Keefe, Bruyette & Woods boosted their price objective on Allstate from $199.00 to $208.00 and gave the company an “outperform” rating in a report on Monday, August 12th. UBS Group lifted their target price on Allstate from $215.00 to $216.00 and gave the stock a “buy” rating in a research report on Tuesday, October 15th. Finally, Raymond James raised their price target on shares of Allstate from $205.00 to $220.00 and gave the stock a “strong-buy” rating in a research note on Friday, October 4th. One analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, Allstate has an average rating of “Moderate Buy” and a consensus price target of $206.44.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.